BiondVax Pharma (BVXV) Reports Q2 Loss of NIS0.05/Share
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
BiondVax Pharma (NASDAQ: BVXV) reported Q2 EPS of (NIS0.05), versus (NIS0.02) reported last year.
For earnings history and earnings-related data on BiondVax Pharma (BVXV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MakeMyTrip Limited (MMYT) Tops Q2 EPS by 5c
- Mack-Cali Realty (CLI) Tops Q3 EPS by 5c; Guides Above the Street
- NeoGenomics (NEO) Tops Q3 EPS by 1c; Boosts FY16 EPS Outlook
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!